Description
The barbiturate class of drugs are traditionally classified as sedatives and central nervous system depressants. Their principle uses are to calm the patient, produce drowsiness, and/or promote sleep. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring of the barbiturates is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes.
Disease/Condition
Drug Monitoring
Location
Specimen
Type
Immunoassay
Analytes Included
- Barbiturates